CH620901A5 - - Google Patents
Download PDFInfo
- Publication number
- CH620901A5 CH620901A5 CH27377A CH27377A CH620901A5 CH 620901 A5 CH620901 A5 CH 620901A5 CH 27377 A CH27377 A CH 27377A CH 27377 A CH27377 A CH 27377A CH 620901 A5 CH620901 A5 CH 620901A5
- Authority
- CH
- Switzerland
- Prior art keywords
- crl
- solution
- group
- mol
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2895/76A GB1538097A (en) | 1976-01-26 | 1976-01-26 | Substituted phenyl-amidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH620901A5 true CH620901A5 (US07456315-20081125-C00041.png) | 1980-12-31 |
Family
ID=9748048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH27377A CH620901A5 (US07456315-20081125-C00041.png) | 1976-01-26 | 1977-01-11 |
Country Status (14)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH630606A5 (en) * | 1977-02-15 | 1982-06-30 | Lafon Labor | Phenylamidine derivatives useful especially in therapeutics |
| EP0011596B1 (de) * | 1978-10-09 | 1981-12-30 | Ciba-Geigy Ag | Neue 2-(alpha-Phenoxy-alkyl)-imidazoline und ihre Salze, deren Herstellung und Verwendung sowie sie enthaltende Mittel zur Bekämpfung von pflanzenschädlichen und tierparasitären Milben |
| DE2961996D1 (en) * | 1978-11-03 | 1982-03-11 | Bayer Ag | N-alkyl-haloacetanilides substituted by an oxime group, processes for their preparation, herbicidal compositions containing them, a process for combating weeds, a process for preparing herbicidal compositions. |
| US4260626A (en) * | 1979-03-26 | 1981-04-07 | Richardson-Merrell Inc. | Tetrahydro and imidazoline antisecretory compounds |
| US4616085A (en) * | 1980-06-19 | 1986-10-07 | Petrolite Corporation | Thioethers of imidazolines |
| FR2506764A1 (fr) * | 1981-05-26 | 1982-12-03 | Synthelabo | Derives d'amidoximes, leur preparation et leur application en therapeutique |
| US5227484A (en) * | 1982-01-14 | 1993-07-13 | Merck Patent Gmbh | Anisotropic compounds having nematic phase and liquid crystal mixtures |
| FR2549049B1 (fr) * | 1983-07-13 | 1986-06-20 | Chauvin Blache Lab | Nouvelles amidines, leur procede de preparation et leur application therapeutique |
| US4659363A (en) * | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
| GB9509930D0 (en) * | 1995-05-17 | 1995-07-12 | Smithkline Beecham Corp | Method for preparing certain acetonitriles |
| CA2637312A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of substituted 2-imidazole of imidazoline derivatives |
| CN101528710B (zh) * | 2006-10-19 | 2012-11-07 | 弗·哈夫曼-拉罗切有限公司 | 氨基甲基-4-咪唑类 |
| RU2009112495A (ru) * | 2006-10-19 | 2010-11-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Аминометил-2-имидазолы со сродством к рецепторам, ассоциированным со следовыми аминами |
| EP2086959B1 (en) * | 2006-11-02 | 2011-11-16 | F. Hoffmann-La Roche AG | Substituted 2-imidazoles as modulators of the trace amine associated receptors |
| CA2669112A1 (en) * | 2006-11-16 | 2008-05-22 | F. Hoffmann-La Roche Ag | Substituted 4-imidazoles |
| ATE509628T1 (de) * | 2006-12-13 | 2011-06-15 | Hoffmann La Roche | Neue 2-imidazole als liganden für trace amine associated receptors (taar) |
| US20080146523A1 (en) | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| BRPI0806940A2 (pt) | 2007-02-02 | 2014-05-06 | Hoffmann La Roche | 2-amino-oxazolinas como ligantes taar1 para distúrbios do snc |
| CA2676944C (en) * | 2007-02-15 | 2016-01-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolines as taar1 ligands |
| CA2691082A1 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| WO2009003867A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| BRPI0813837A2 (pt) * | 2007-07-27 | 2015-01-06 | Hoffmann La Roche | 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar |
| AU2008281877A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of CNS disorders |
| KR101167773B1 (ko) * | 2007-08-03 | 2012-07-24 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ１ 리간드로서의 피리딘카복스아마이드 및 벤즈아마이드 유도체 |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| EP2321287B1 (en) * | 2008-07-24 | 2015-11-11 | F. Hoffmann-La Roche AG | 4,5-dihydro-oxazol-2-yl derivatives |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| JPWO2013137371A1 (ja) * | 2012-03-15 | 2015-08-03 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
| KR102537050B1 (ko) | 2016-03-17 | 2023-05-26 | 에프. 호프만-라 로슈 아게 | Taar의 작용제로서 활성을 갖는 5-에틸-4-메틸-피라졸-3-카복스아미드 유도체 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT643195A (US07456315-20081125-C00041.png) * | 1960-01-01 | |||
| US3115525A (en) * | 1960-04-21 | 1963-12-24 | Wassermann S P A Soc It Per Sp | Halogen-substituted amidoximes |
| US3394181A (en) * | 1964-06-29 | 1968-07-23 | Sterling Drug Inc | Phenoxy-lower-alkyl-amidoximes and phenylamino-lower-alkyl-amidoximes |
| US3445517A (en) * | 1966-06-03 | 1969-05-20 | Lilly Co Eli | Aryl acetamidines |
| FR2036958A6 (US07456315-20081125-C00041.png) * | 1969-04-23 | 1970-12-31 | Orsymonde | |
| FR2149264B1 (US07456315-20081125-C00041.png) * | 1971-08-13 | 1974-09-06 | Orsymonde | |
| US3775478A (en) * | 1972-05-30 | 1973-11-27 | Dow Chemical Co | Substituted phenylthioamidines |
| FR2207706B1 (US07456315-20081125-C00041.png) * | 1972-11-24 | 1975-11-28 | Orsymonde | |
| US3939912A (en) * | 1975-03-21 | 1976-02-24 | Continental Oil Company | Method for reducing the production of water from oil wells |
-
1976
- 1976-01-26 GB GB2895/76A patent/GB1538097A/en not_active Expired
-
1977
- 1977-01-11 CH CH27377A patent/CH620901A5/fr not_active IP Right Cessation
- 1977-01-20 FR FR7701595A patent/FR2338927A1/fr active Granted
- 1977-01-20 DE DE2702119A patent/DE2702119C2/de not_active Expired
- 1977-01-20 IE IE110/77A patent/IE44416B1/en not_active IP Right Cessation
- 1977-01-24 CA CA270,277A patent/CA1074797A/en not_active Expired
- 1977-01-24 ES ES455294A patent/ES455294A1/es not_active Expired
- 1977-01-25 DK DK30277A patent/DK30277A/da not_active Application Discontinuation
- 1977-01-25 BE BE174356A patent/BE850723A/xx not_active IP Right Cessation
- 1977-01-25 LU LU76641A patent/LU76641A1/xx unknown
- 1977-01-25 US US05/762,774 patent/US4146647A/en not_active Expired - Lifetime
- 1977-01-25 SE SE7700777A patent/SE440501B/xx not_active IP Right Cessation
- 1977-01-26 JP JP52007602A patent/JPS5953895B2/ja not_active Expired
- 1977-01-26 NL NLAANVRAGE7700806,A patent/NL188573C/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2338927B1 (US07456315-20081125-C00041.png) | 1980-10-10 |
| IE44416L (en) | 1977-07-26 |
| JPS52105131A (en) | 1977-09-03 |
| DE2702119A1 (de) | 1977-07-28 |
| SE7700777L (sv) | 1977-07-27 |
| IE44416B1 (en) | 1981-11-18 |
| DE2702119C2 (de) | 1986-07-10 |
| DK30277A (da) | 1977-07-27 |
| CA1074797A (en) | 1980-04-01 |
| NL188573C (nl) | 1992-08-03 |
| GB1538097A (en) | 1979-01-10 |
| JPS5953895B2 (ja) | 1984-12-27 |
| NL7700806A (nl) | 1977-07-28 |
| FR2338927A1 (fr) | 1977-08-19 |
| BE850723A (fr) | 1977-05-16 |
| US4146647A (en) | 1979-03-27 |
| SE440501B (sv) | 1985-08-05 |
| LU76641A1 (US07456315-20081125-C00041.png) | 1977-06-24 |
| ES455294A1 (es) | 1978-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH620901A5 (US07456315-20081125-C00041.png) | ||
| CA1120928A (en) | Acetohydroxamic acids | |
| EP0097071A1 (fr) | Dérivés de benzhydrylsulfinylacétamide et leur utilisation en thérapeutique | |
| CH628026A5 (fr) | Derives d'acetamide et composition therapeutique contenant ces derives. | |
| NO143219B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| EP0110781B1 (fr) | (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant | |
| CA1054151A (fr) | Derives de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, leur procede de preparation et leur application en therapeutique | |
| CH625518A5 (US07456315-20081125-C00041.png) | ||
| EP0420716A2 (fr) | Benzodiazépines, leur procédé et intermédiaires de préparation et leur application en thérapeutique | |
| CH630606A5 (en) | Phenylamidine derivatives useful especially in therapeutics | |
| CH625795A5 (US07456315-20081125-C00041.png) | ||
| EP0037344B1 (fr) | Amino-alcoxy pyrazoles, procédé pour leur préparation, et médicaments les contenant | |
| US4367239A (en) | Nitrosourea derivatives, pharmaceutical compositions thereof and method of preparation | |
| EP0026989B1 (en) | Nitrosourea derivatives, process for preparing them, and pharmaceutical compositions containing them | |
| EP0234970B1 (fr) | Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique | |
| EP0158545B1 (fr) | Dérivés d'acide [alpha-(alkylaminométhyl)-benzylthio]-acétique, procédé de préparation et utilisation en thérapeutique | |
| EP0061406B1 (fr) | Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique | |
| US3262978A (en) | O-arylamino-and-aralkyl-amino-alkylhydroxyl-amines | |
| FR2553411A1 (fr) | Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique | |
| EP0502110B1 (fr) | Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique | |
| EP0258134A1 (fr) | Compsitions thérapeutiques contenant des dérivés du benzhydrylthiométhane | |
| CH658786A5 (fr) | Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters. | |
| CH645356A5 (fr) | 4-aminopyrazolidines. | |
| FR2460668A1 (fr) | Derives de 2-amino-1-phenyl-1-ethanol, utiles en tant que medicaments et leur procede de preparation | |
| FR2690917A1 (fr) | Aminoesters, leur procédé de préparation et leur application en thérapeutique. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |